According to this latest study, the 2021 growth of Infectious Disease In-vitro Diagnostic will have significant change from previous year. By the most conservative estimates of global Infectious Disease In-vitro Diagnostic market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ 55 million in 2020. Over the next five years the Infectious Disease In-vitro Diagnostic market will register a 4.0% CAGR in terms of revenue, the global market size will reach US$ 64 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease In-vitro Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Immunoassay
Molecular Diagnostics
Microbiology
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
COVID-19
MRSA
Clostridium Difficile
Respiratory Virus
TB and Drug-resistant TB
Chlamydia
Gonorrhea
HPV
HIV
Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
BD
BioM?rieux SA
Abbott
Quidel Corporation
OraSure Technologies, Inc.
Hologic, Inc. (Gen Probe)
Danaher
QIAGEN
Roche
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Infectious Disease In-vitro Diagnostic Market Size 2016-2026
2.1.2 Infectious Disease In-vitro Diagnostic Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Infectious Disease In-vitro Diagnostic Segment by Type
2.2.1 Immunoassay
2.2.2 Immunoassay
2.2.3 Microbiology
2.2.4 Others
2.3 Infectious Disease In-vitro Diagnostic Market Size by Type
2.3.1 Global Infectious Disease In-vitro Diagnostic Market Size CAGR by Type
2.3.2 Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Type (2016-2021)
2.4 Infectious Disease In-vitro Diagnostic Segment by Application
2.4.1 COVID-19
2.4.2 MRSA
2.4.3 Clostridium Difficile
2.4.4 Respiratory Virus
2.4.5 TB and Drug-resistant TB
2.4.6 Chlamydia
2.4.7 Gonorrhea
2.4.8 HPV
2.4.9 HIV
2.4.10 Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
2.5 Infectious Disease In-vitro Diagnostic Market Size by Application
2.5.1 Global Infectious Disease In-vitro Diagnostic Market Size CAGR by Application
2.5.2 Global Infectious Disease In-vitro Diagnostic Market Size Market Share by Application (2016-2021)
3 Infectious Disease In-vitro Diagnostic Market Size by Players
3.1 Infectious Disease In-vitro Diagnostic Market Size Market Share by Players
3.1.1 Global Infectious Disease In-vitro Diagnostic Revenue by Players (2019-2021E)
3.1.2 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Players (2019-2021E)
3.2 Global Infectious Disease In-vitro Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Infectious Disease In-vitro Diagnostic by Regions
4.1 Infectious Disease In-vitro Diagnostic Market Size by Regions (2016-2021)
4.2 Americas Infectious Disease In-vitro Diagnostic Market Size Growth (2016-2021)
4.3 APAC Infectious Disease In-vitro Diagnostic Market Size Growth (2016-2021)
4.4 Europe Infectious Disease In-vitro Diagnostic Market Size Growth (2016-2021)
4.5 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size Growth (2016-2021)
5 Americas
5.1 Americas Infectious Disease In-vitro Diagnostic Market Size by Country (2016-2021)
5.2 Americas Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021)
5.3 Americas Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease In-vitro Diagnostic Market Size by Region (2016-2021)
6.2 APAC Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021)
6.3 APAC Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Infectious Disease In-vitro Diagnostic by Country (2016-2021)
7.2 Europe Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021)
7.3 Europe Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infectious Disease In-vitro Diagnostic by Region (2016-2021)
8.2 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021)
8.3 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Infectious Disease In-vitro Diagnostic Market Forecast
10.1 Global Infectious Disease In-vitro Diagnostic Forecast by Regions (2021-2026)
10.1.1 Global Infectious Disease In-vitro Diagnostic Forecast by Regions (2021-2026)
10.1.2 Americas Infectious Disease In-vitro Diagnostic Forecast
10.1.3 APAC Infectious Disease In-vitro Diagnostic Forecast
10.1.4 Europe Infectious Disease In-vitro Diagnostic Forecast
10.1.5 Middle East & Africa Infectious Disease In-vitro Diagnostic Forecast
10.2 Americas Infectious Disease In-vitro Diagnostic Forecast by Countries (2021-2026)
10.2.1 United States Infectious Disease In-vitro Diagnostic Market Forecast
10.2.2 Canada Infectious Disease In-vitro Diagnostic Market Forecast
10.2.3 Mexico Infectious Disease In-vitro Diagnostic Market Forecast
10.2.4 Brazil Infectious Disease In-vitro Diagnostic Market Forecast
10.3 APAC Infectious Disease In-vitro Diagnostic Forecast by Region (2021-2026)
10.3.1 China Infectious Disease In-vitro Diagnostic Market Forecast
10.3.2 Japan Infectious Disease In-vitro Diagnostic Market Forecast
10.3.3 Korea Infectious Disease In-vitro Diagnostic Market Forecast
10.3.4 Southeast Asia Infectious Disease In-vitro Diagnostic Market Forecast
10.3.5 India Infectious Disease In-vitro Diagnostic Market Forecast
10.3.6 Australia Infectious Disease In-vitro Diagnostic Market Forecast
10.4 Europe Infectious Disease In-vitro Diagnostic Forecast by Country (2021-2026)
10.4.1 Germany Infectious Disease In-vitro Diagnostic Market Forecast
10.4.2 France Infectious Disease In-vitro Diagnostic Market Forecast
10.4.3 UK Infectious Disease In-vitro Diagnostic Market Forecast
10.4.4 Italy Infectious Disease In-vitro Diagnostic Market Forecast
10.4.5 Russia Infectious Disease In-vitro Diagnostic Market Forecast
10.5 Middle East & Africa Infectious Disease In-vitro Diagnostic Forecast by Region (2021-2026)
10.5.1 Egypt Infectious Disease In-vitro Diagnostic Market Forecast
10.5.2 South Africa Infectious Disease In-vitro Diagnostic Market Forecast
10.5.3 Israel Infectious Disease In-vitro Diagnostic Market Forecast
10.5.4 Turkey Infectious Disease In-vitro Diagnostic Market Forecast
10.5.5 GCC Countries Infectious Disease In-vitro Diagnostic Market Forecast
10.6 Global Infectious Disease In-vitro Diagnostic Forecast by Type (2021-2026)
10.7 Global Infectious Disease In-vitro Diagnostic Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Infectious Disease In-vitro Diagnostic Product Offered
11.1.3 BD Infectious Disease In-vitro Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 BioM